Received Mar 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (TRUMENBA) | PFIZER\WYETH | UNK | — | — |
Pain, redness, and swelling that remained for 3 days following the injection; Pain, redness, and swelling that remained for 3 days following the injection; Pain, redness, and swelling that remained for 3 days following the injection; This is a spontaneous report received from a Physician from a sales representative. An adolescent male patient received meningococcal group b Rlp2086 (TRUMENBA), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. It was unknown if the patient received any other vaccines on the same date as the vaccine(s). It was unknown if the patient received any other vaccines within 4 weeks prior to the vaccine(s). It was unknown if the patient was taking any other medications within 2 weeks of the event starting. The following information was reported: PAIN (non-serious), ERYTHEMA (non-serious), SWELLING (non-serious), outcome "recovered" and all described as "Pain, redness, and swelling that remained for 3 days following the injection". Therapeutic measures were not taken as a result of pain, erythema, swelling. Additional information: There were two patients who reported pain, redness, and swelling that remained for 3 days following the injection. The information on the batch/lot number for meningococcal group b Rlp2086 will be requested and submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202600050226 Same suspect product and event, different patient;